Additional reports suggest that tumors demonstrating increased CD8 + T-cell infiltration have favorable clinical outcomes [44, 45], and that increased tumor-infiltrating lymphocytes are associated with lower rates of relapse [46]. Here, CD8A is linked to neoplasm.